zopolrestat has been researched along with indomethacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Y; Hu, X; Li, Q; Peng, X; Yuan, M; Zhai, J; Zhang, H; Zhang, L; Zhao, Y | 1 |
| Chen, YJ; Li, J; Quilley, J | 1 |
2 other study(ies) available for zopolrestat and indomethacin
| Article | Year |
|---|---|
Zopolrestat as a human glyoxalase I inhibitor and its structural basis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiazoles; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Indomethacin; Lactoylglutathione Lyase; Mice; Phthalazines; Protein Binding; Protein Structure, Tertiary | 2013 |
Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
Topics: Aldehyde Reductase; Animals; Antioxidants; Arachidonic Acid; Benzothiazoles; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Indomethacin; Insulin; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Perfusion; Phthalazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Spin Labels; Tyrosine | 2008 |